Kaplan–Meier analysis showed that increased TRIM11 expression was significantly correlated with decreased overall survival (OS) and progression-free survival (PFS) in patients with NPC (Fig. 1e–g). The gene discussed is TRIM11; the disease is nasopharyngeal carcinoma.